Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer

International Journal of Oncology

Volumn 42, Issue 3, 2013, Pages 894-902

  Tanaka, Tomokazu ^a   Nakamura, Jun ^a   Kitajima, Yoshihiko ^a,b   Kai, Keita ^a   Miyake, Shuusuke ^a   Hiraki, Masatsugu ^a   Ide, Takao ^a   Koga, Yasuo ^a   Noshiro, Hirokazu ^a  

^a SAGA UNIVERSITY   (Japan)

^b Miyaki gun   (Japan)

Author keywords

Epigenetic modification; Gastric cancer; pS2; Survival; Trefoil factor 1

Indexed keywords

PROTEIN; TREFOIL FACTOR 1; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER PATIENT; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; CONTROLLED STUDY; CYTOPLASM; DNA METHYLATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE LOSS; GENE SEQUENCE; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; SURVIVAL; TATA BOX; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84873628747     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1759     Document Type: Article

References (33)

1. Wong WM, Poulsom R and Wright NA: Trefoil peptides. Gut 44: 890-895, 1999. (Pubitemid 29244230)
2. Hoffmann W and Jagla W: Cell type specific expression of secretory TFF peptides: colocalization with mucins and synthesis in the brain. Int Rev Cytol 213: 147-181, 2002. (Pubitemid 34112918)
3. Taupin D and Podolsky DK: Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 4: 721-732, 2003. (Pubitemid 37082187)
4. Thim L: Trefoil peptides: from structure to function. Cell Mol Life Sci 53: 888-903, 1997. (Pubitemid 28021502)
5. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A and Chambon P: Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 10: 7895-7903, 1982.
6. Rio MC, Bellocq JP, Daniel JY, et al: Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 241: 705-708, 1988.
7. Tomasetto C, Masson R, Linares JL, Wendling C, Lefebvre O, Chenard MP and Rio MC: pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology 118: 70-80, 2000. (Pubitemid 30020374)
8. Hoffmann W, Jagla W and Wiede A: Molecular medicine of TFF-peptides: from gut to brain. Histol Histopathol 16: 319-334, 2001. (Pubitemid 32094047)
9. Lefebvre O, Chenard MP, Masson R, et al: Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274: 259-262, 1996. (Pubitemid 26353205)
10. Colombel M, Dante R, Bouvier R, Ribieras S, Pangaud C, Marechal JM and Lasne Y: Differential RNA expression of the pS2 gene in the human benign and malignant prostatic tissue. J Urol 162: 927-930, 1999. (Pubitemid 29436919)
11. Buache E, Etique N, Alpy F, et al: Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice. Oncogene 30: 3261-3273, 2011.
12. Arumugam T, Brandt W, Ramachandran V, et al: Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis. Pancreas 40: 815-822, 2011.
13. McChesney PA, Aiyar SE, Lee OJ, Zaika A, Moskaluk C, Li R and El-Rifai W: Cofactor of BRCA1: a novel transcription factor regulator in upper gastrointestinal adenocarcinomas. Cancer Res 66: 1346-1353, 2006. (Pubitemid 43259913)
14. Milne AN, Carvalho R, Morsink FM, Musler AR, de Leng WW, Ristimäki A and Offerhaus GJ: Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers. Mod Pathol 19: 564-572, 2006.
15. Gött P, Beck S, Machado JC, Carneiro F, Schmitt H and Blin N: Human trefoil peptides: genomic structure in 21q22.3 and coordinated expression. Eur J Hum Genet 4: 308-315, 1996.
16. Beck S, Sommer P, Blin N and Gött P: 5'-flanking motifs control cell-specific expression of trefoil factor genes (TFF). Int J Mol Med 2: 353-361, 1998.
17. Al-azzeh ED, Fegert P, Blin N and Gött P: Transcription factor GATA-6 activates expression of gastroprotective trefoil genes TFF1 and TFF2. Biochim Biophys Acta 1490: 324-332, 2000. (Pubitemid 30103805)
18. Beck S, Sommer P, dos Santos Silva E, Blin N and Gött P: Hepatocyte nuclear factor 3 (winged helix domain) activates trefoil factor gene TFF1 through a binding motif adjacent to the TATAA box. DNA Cell Biol 18: 157-164, 1999. (Pubitemid 29095995)
19. Hernández C, Santamatilde E, McCreath KJ, et al: Induction of trefoil factor (TFF) 1, TFF2 and TFF3 by hypoxia is mediated by hypoxia inducible factor-1: implications for gastric mucosal healing. Br J Pharmacol 156: 262-272, 2009.
20. Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma: 3rd English ed. Gastric Cancer 14: 101-112, 2011.
21. Yanagihara K, Ito A, Toge T and Numoto M: Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 53: 5815-5821, 1993. (Pubitemid 23360293)
22. Yanagihara K, Tanaka H, Takigahira M, et al: Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice. Cancer Sci 95: 575-582, 2004. (Pubitemid 39089638)
23. Nakamura J, Kitajima Y, Kai K, et al: Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer. Am J Pathol 178: 515-524, 2011.
24. Babyatsky MW, deBeaumont M, Thim L and Podolsky DK: Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. Gastroenterology 110: 489-497, 1996. (Pubitemid 26043882)
25. Playford RJ, Marchbank T, Goodlad RA, Chinery RA, Poulsom R and Hanby AM: Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci USA 93: 2137-2142, 1996. (Pubitemid 26079894)
26. Peterson DE, Barker NP, Akhmadullina LI, et al: Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy. J Clin Oncol 27: 4333-4338, 2009.
27. Park WS, Oh RR, Park JY, et al: Mapping of a new target region of allelic loss at 21q22 in primary gastric cancers. Cancer Lett 159: 15-21, 2000.
28. Park WS, Oh RR, Park JY, et al: Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 119: 691-698, 2000.
29. Carvalho R, Kayademir T, Soares P, et al: Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma. Lab Invest 82: 1319-1326, 2002. (Pubitemid 35191535)
30. Beckler AD, Roche JK, Harper JC, et al: Decreased abundance of trefoil factor 1 transcript in the majority of gastric carcinomas. Cancer 98: 2184-2191, 2003. (Pubitemid 37392422)
31. Yio X, Diamond M, Zhang JY, Weinstein H, Wang LH, Werther L and Itzkowitz S: Trefoil factor family-1 mutations enhance gastric cancer cell invasion through distinct signaling pathways. Gastroenterology 130: 1696-1706, 2006. (Pubitemid 43668862)
32. Lifton RP, Goldberg ML, Karp RW and Hogness DS: The organization of the histone genes in Drosophila melanogaster: functional and evolutionary implications. Cold Spring Harb Symp Quant Biol 42: 1047-1051, 1978. (Pubitemid 9077221)
33. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P and Giallongo A: Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271: 32529-32537, 1996.